Netherlands· NL-0de2802ae9a9
Atrovent Unit Dose 500 microgram/2 ml, verneveloplossing
A ipratropium bromide product containing ipratropiumbromide 1-water, registered in Netherlands by Boehringer Ingelheim B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ipratropium bromide is registered in 13 of 19 countries.
Countries holding a registration under ATC R03BB01 (ipratropium bromide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Ipratropium bromide · ATC R03BB01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- IPRATROPIUMBROMIDE 1-WATER
- Manufacturer
- Boehringer Ingelheim B.V.
- Country
- Netherlands (NL)
- ATC code
- R03BB01
- ATC class
- Ipratropium bromide
- Defined daily dose
- 0.12 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id12869
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for ipratropium bromide.
Graded by severity as the source publishes them — 114 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ipratropium bromide · interactions on record
114 records
- 114 moderate
Most severe, free to view
- DicycloverineA03AA07moderate
- PropanthelineA03AB05moderate
- MepenzolateA03AB12moderate
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ipratropium bromide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceIPRATROPIUM AGUETTANT ADULTES 0,5 mg/2 ml, solution pour inhalation par nébuliseur en récipient unidoseAGUETTANT
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorAbacus Medicine A/S
- BelgiumAtrovent 0.5 mg/2 mlBoehringer Ingelheim
- IrelandAtrovent 250 UDVs 250 micrograms/ 1ml Nebuliser SolutionBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- NorwayAtroventBoehringer Ingelheim International GmbH
- SpainATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADORBoehringer Ingelheim Espana S.A.
- IcelandAtroventBoehringer Ingelheim International GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- France · Atrovent, Atrovent Adultes
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d74f4538-690b-4bd8-8178-260e5bd084c2 GET /v1/drugs/d74f4538-690b-4bd8-8178-260e5bd084c2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Verneveloplossing",
"route": "Inhalatie",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h12869_smpc.pdf",
"strength": null,
"atc_label": "Ipratropium Bromide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg12869",
"excipients": [
"NATRIUMCHLORIDE",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"IPRATROPIUMBROMIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h12869.pdf",
"authorised_at": "1988/11/30",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "12869",
"additional_monitoring": "N"
}See everything about ipratropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.